MCL1 inhibitors S63845/MIK665 plus Navitoclax synergistically kill difficult-to-treat melanoma cells
MCL1 抑制剂 S63845/MIK665 与 Navitoclax 协同杀死难以治疗的黑色素瘤细胞
期刊:Cell Death & Disease
影响因子:8.1
doi:10.1038/s41419-020-2646-2
Nabanita Mukherjee, Jenette Skees, Kaleb J Todd, Drake A West, Karoline A Lambert, William A Robinson, Carol M Amato, Kasey L Couts, Robert Van Gulick, Morgan MacBeth, Kelsey Nassar, Aik-Choon Tan, Zili Zhai, Mayumi Fujita, Stacey M Bagby, Chiara R Dart, James R Lambert, David A Norris, Yiqun G Shel